ARCT-154 Self-Amplifying RNA SARS-CoV-2 Vaccine
ARCT-154-01
Phase 3 mab completed
Quick answer
ARCT-154 Self-Amplifying RNA SARS-CoV-2 Vaccine for COVID-19 Vaccines is a Phase 3 program (mab) at Arcturus Therapeutics Holdings with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Arcturus Therapeutics Holdings
- Indication
- COVID-19 Vaccines
- Phase
- Phase 3
- Modality
- mab
- Status
- completed